Britannia Life Sciences Inc. Reports Fourth Quarter and Fiscal Year 2024 Financial Results Page 1

Toronto, Ontario–(Newsfile Corp. – September 2, 2024) – Britannia Life Sciences Inc. (CSE: BLAB) (“Britain” or the “Company“) is pleased to report financial results for the year ended March 31, 2024. The Company’s audited financial statements and the related management’s discussion and analysis for the year ended March 31, 2024 are available for review on SEDAR+ (www.sedarplus.ca) under the Company’s issuer profile.

Financial highlights for the fiscal year ended March 31, 2024 include (unless otherwise stated, all amounts are in Canadian dollars):